[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 55,654
Sort by:

2019 Vision Disorders Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Vision Disorders Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Vision Disorders. It presents in-depth analysis of Vision Disorders clinical trials across markets and companies ...

April 2019 286 pages

2019 Vitamin A Deficiency Disorders Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... report- “2019 Vitamin A Deficiency Disorders Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Vitamin A Deficiency Disorders. It presents in-depth analysis of Vitamin A Deficiency Disorders clinical trials ...

April 2019 120 pages

2019 Vitamin B12 Deficiency (Hypocobalaminemia) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... report- “2019 Vitamin B12 Deficiency (Hypocobalaminemia) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Vitamin B12 Deficiency (Hypocobalaminemia). It presents in-depth analysis of Vitamin B12 Deficiency (Hypocobalaminemia) clinical trials ...

April 2019 55 pages

2019 Vitiligo Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Vitiligo Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Vitiligo. It presents in-depth analysis of Vitiligo clinical trials across markets and companies ...

April 2019 74 pages

2019 Vitreomacular Adhesion Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Vitreomacular Adhesion Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Vitreomacular Adhesion. It presents in-depth analysis of Vitreomacular Adhesion clinical trials across markets and companies ...

April 2019 45 pages

2019 Vocal Cord Paralysis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Vocal Cord Paralysis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Vocal Cord Paralysis. It presents in-depth analysis of Vocal Cord Paralysis clinical trials ...

April 2019 38 pages

2019 Voice Disorders Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Voice Disorders Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Voice Disorders. It presents in-depth analysis of Voice Disorders clinical trials across markets and companies ...

April 2019 51 pages

2019 Von Hippel-Lindau Syndrome Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Von Hippel-Lindau Syndrome Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Von Hippel-Lindau Syndrome. It presents in-depth analysis of Von Hippel-Lindau Syndrome clinical trials ...

April 2019 45 pages

2019 Von Willebrand Disease (Factor VIII Deficiency) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... trial report- “2019 Von Willebrand Disease (Factor VIII Deficiency) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Von Willebrand Disease (Factor VIII Deficiency ...

April 2019 44 pages

2019 Vulvar Cancer Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Vulvar Cancer Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Vulvar Cancer. It presents in-depth analysis of Vulvar Cancer clinical trials across markets and companies ...

April 2019 60 pages

2019 Vulvovaginal Candidiasis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Vulvovaginal Candidiasis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Vulvovaginal Candidiasis. It presents in-depth analysis of Vulvovaginal Candidiasis clinical trials across markets and companies ...

April 2019 68 pages

2019 Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... - “2019 Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma). It presents in-depth analysis of Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma ...

April 2019 360 pages

2019 Warts Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Warts Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Warts. It presents in-depth analysis of Warts clinical trials across markets and companies ...

April 2019 111 pages

2019 West Nile Virus Infections Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... report- “2019 West Nile Virus Infections Clinical Trials Study” provides complete list of trials completed, ongoing and planned for West Nile Virus Infections. It presents in-depth analysis of West Nile Virus Infections clinical trials ...

April 2019 37 pages

2019 Wet (Neovascular / Exudative) Macular Degeneration Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... trial report- “2019 Wet (Neovascular / Exudative) Macular Degeneration Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Wet (Neovascular / Exudative) Macular Degeneration ...

April 2019 255 pages

2019 Wheezing Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Wheezing Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Wheezing. It presents in-depth analysis of Wheezing clinical trials across markets and companies ...

April 2019 95 pages

2019 Wilms' Tumor (Nephroblastoma) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Wilms' Tumor (Nephroblastoma) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Wilms' Tumor (Nephroblastoma). It presents in-depth analysis of Wilms' Tumor (Nephroblastoma) clinical trials ...

April 2019 110 pages

2019 Wiskott-Aldrich Syndrome Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Wiskott-Aldrich Syndrome Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Wiskott-Aldrich Syndrome. It presents in-depth analysis of Wiskott-Aldrich Syndrome clinical trials across markets and companies ...

April 2019 46 pages

2019 Wrinkles Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Wrinkles Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Wrinkles. It presents in-depth analysis of Wrinkles clinical trials across markets and companies ...

April 2019 112 pages

2019 Xerosis (Dry Skin) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Xerosis (Dry Skin) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Xerosis (Dry Skin). It presents in-depth analysis of Xerosis (Dry Skin) clinical trials ...

April 2019 41 pages

2019 Xerostomia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Xerostomia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Xerostomia. It presents in-depth analysis of Xerostomia clinical trials across markets and companies ...

April 2019 139 pages

2019 X-Linked Agammaglobulinemia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 X-Linked Agammaglobulinemia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for X-Linked Agammaglobulinemia. It presents in-depth analysis of X-Linked Agammaglobulinemia clinical trials across markets and companies ...

April 2019 40 pages

2019 Yellow Fever Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Yellow Fever Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Yellow Fever. It presents in-depth analysis of Yellow Fever clinical trials across markets and companies ...

April 2019 62 pages

2019 Zika Virus Infections Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Zika Virus Infections Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Zika Virus Infections. It presents in-depth analysis of Zika Virus Infections clinical trials ...

April 2019 50 pages

2019 Zollinger-Ellison Syndrome (Gastrinoma) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Zollinger-Ellison Syndrome (Gastrinoma) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Zollinger-Ellison Syndrome (Gastrinoma). It presents in-depth analysis of Zollinger-Ellison Syndrome (Gastrinoma) clinical trials ...

April 2019 120 pages

Acromegaly - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... action and recent developments associated with each drug. Companies participating in Acromegaly pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Acromegaly pipeline and treatment landscape Complete list of drug candidates from discovery to pre- ...

April 2019 80 pages

Acute Kidney Injury - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... . Report assists users in taking actionable steps Acute Kidney Injury pipeline report enables users to gain clear understanding into ... business in Acute Kidney Injury treatment pipeline. The report includes: The research work provides comprehensive overview of Acute Kidney Injury pipeline and treatment ...

April 2019 140 pages

Acute Renal Failure (ARF) - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... developments associated with each drug. Companies participating in Acute Renal Failure (ARF) pipeline Profiled in detail Key players actively ... business in Acute Renal Failure (ARF) treatment pipeline. The report includes: The research work provides comprehensive overview of Acute Renal Failure (ARF) pipeline ...

April 2019 144 pages

Alcoholic Hepatitis - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... developments associated with each drug. Companies participating in Alcoholic Hepatitis pipeline Profiled in detail Key ... Alcoholic Hepatitis treatment pipeline. The report includes: The research work provides comprehensive overview of Alcoholic Hepatitis pipeline and treatment landscape Complete list of drug ...

April 2019 65 pages

Amyloidosis - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... action and recent developments associated with each drug. Companies participating in Amyloidosis pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Amyloidosis pipeline and treatment landscape Complete list of drug candidates from discovery to pre- ...

April 2019 100 pages

Anaphylaxis - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... action and recent developments associated with each drug. Companies participating in Anaphylaxis pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Anaphylaxis pipeline and treatment landscape Complete list of drug candidates from discovery to pre- ...

April 2019 40 pages

Atypical (Nondiarrhea associated) Hemolytic Uremic Syndrome - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... for new business in Atypical (Nondiarrhea associated) Hemolytic Uremic Syndrome treatment pipeline. The report includes: The research work provides comprehensive overview of Atypical (Nondiarrhea associated) Hemolytic Uremic Syndrome pipeline and ...

April 2019 55 pages

Benign Prostatic Hyperplasia - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... Report assists users in taking actionable steps Benign Prostatic Hyperplasia pipeline report enables users to gain clear understanding ... in Benign Prostatic Hyperplasia treatment pipeline. The report includes: The research work provides comprehensive overview of Benign Prostatic Hyperplasia pipeline and ...

April 2019 89 pages

Birch Pollen Allergy - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... . Report assists users in taking actionable steps Birch Pollen Allergy pipeline report enables users to gain clear understanding into ... business in Birch Pollen Allergy treatment pipeline. The report includes: The research work provides comprehensive overview of Birch Pollen Allergy pipeline and treatment ...

April 2019 50 pages

Cat Allergy - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... developments, pharmacological action and recent developments associated with each drug. Companies participating in Cat Allergy pipeline Profiled in detail Key players actively participating in constipation ...

April 2019 35 pages

Cedar Pollen Allergy - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... . Report assists users in taking actionable steps Cedar Pollen Allergy pipeline report enables users to gain clear understanding into ... business in Cedar Pollen Allergy treatment pipeline. The report includes: The research work provides comprehensive overview of Cedar Pollen Allergy pipeline and treatment ...

April 2019 40 pages

Celiac Disease - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... developments, pharmacological action and recent developments associated with each drug. Companies participating in Celiac Disease pipeline Profiled in detail Key players actively participating in constipation ...

April 2019 88 pages

Cervical Intraepithelial Neoplasia (CIN) - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... with each drug. Companies participating in Cervical Intraepithelial Neoplasia (CIN) pipeline Profiled in detail Key players ... Cervical Intraepithelial Neoplasia (CIN) treatment pipeline. The report includes: The research work provides comprehensive overview of Cervical Intraepithelial Neoplasia (CIN) ...

April 2019 72 pages

Colitis - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... action and recent developments associated with each drug. Companies participating in Colitis pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Colitis pipeline and treatment landscape Complete list of drug candidates from discovery to pre-registration ...

April 2019 100 pages

Constipation - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... recent developments associated with each drug. Companies participating in Constipation pipeline Profiled in detail Key players actively participating in constipation pipeline are profiled along with their ...

April 2019 77 pages

Contrast Induced Nephropathy - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... Report assists users in taking actionable steps Contrast Induced Nephropathy pipeline report enables users to gain clear understanding ... in Contrast Induced Nephropathy treatment pipeline. The report includes: The research work provides comprehensive overview of Contrast Induced Nephropathy pipeline and ...

April 2019 35 pages

Cushing Syndrome - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... developments, pharmacological action and recent developments associated with each drug. Companies participating in Cushing Syndrome pipeline Profiled in detail Key players actively participating in constipation ...

April 2019 58 pages

Diabetic Foot Ulcers - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... . Report assists users in taking actionable steps Diabetic Foot Ulcers pipeline report enables users to gain clear understanding into ... business in Diabetic Foot Ulcers treatment pipeline. The report includes: The research work provides comprehensive overview of Diabetic Foot Ulcers pipeline and treatment ...

April 2019 145 pages

Diabetic Gastroparesis - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... associated with each drug. Companies participating in Diabetic Gastroparesis pipeline Profiled in detail Key ... Diabetic Gastroparesis treatment pipeline. The report includes: The research work provides comprehensive overview of Diabetic Gastroparesis pipeline and treatment landscape Complete list of drug ...

April 2019 55 pages

Diabetic Neuropathy - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... developments associated with each drug. Companies participating in Diabetic Neuropathy pipeline Profiled in detail Key ... Diabetic Neuropathy treatment pipeline. The report includes: The research work provides comprehensive overview of Diabetic Neuropathy pipeline and treatment landscape Complete list of drug ...

April 2019 130 pages

Diabetic Peripheral Neuropathy - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... Report assists users in taking actionable steps Diabetic Peripheral Neuropathy pipeline report enables users to gain clear understanding ... in Diabetic Peripheral Neuropathy treatment pipeline. The report includes: The research work provides comprehensive overview of Diabetic Peripheral Neuropathy pipeline and ...

April 2019 81 pages

Diarrhea - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... action and recent developments associated with each drug. Companies participating in Diarrhea pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Diarrhea pipeline and treatment landscape Complete list of drug candidates from discovery to pre-registration ...

April 2019 142 pages

End Stage Kidney Disease - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... associated with each drug. Companies participating in End Stage Kidney Disease pipeline Profiled in detail Key players actively participating ... in End Stage Kidney Disease treatment pipeline. The report includes: The research work provides comprehensive overview of End Stage Kidney Disease pipeline ...

April 2019 42 pages

End Stage Renal Disease (ESRD) - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... associated with each drug. Companies participating in End Stage Renal Disease (ESRD) pipeline Profiled in detail Key players actively ... in End Stage Renal Disease (ESRD) treatment pipeline. The report includes: The research work provides comprehensive overview of End Stage Renal Disease (ESRD) pipeline ...

April 2019 40 pages

Endometriosis - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... action and recent developments associated with each drug. Companies participating in Endometriosis pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Endometriosis pipeline and treatment landscape Complete list of drug candidates from discovery to pre- ...

April 2019 130 pages

Filters

Search

Categories

12,968
1,223
4,429
2
1
8,271
2,818
15,138
67
8,921
1
1,229
586

Publishers

55,654

Regions

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
55,617

Price

Date

Pages

Offers